Literature DB >> 11130675

Plant natural products active against snake bite--the molecular approach.

W B Mors1, M C Nascimento, B M Pereira, N A Pereira.   

Abstract

The article surveys the substances identified in plants reputed to neutralize the effects of snake venoms. Protective activity of many of them against the lethal action of the venom of the jararaca (Bothrops jararaca) snake was confirmed by biological assays. It was shown that all belong to chemical classes capable of interacting with macromolecular targets--receptors and enzymes. In a few cases it has been shown that exogenous natural micromolecules can mimic the biological activity of endogenous macromolecules. From the evidence presented, it can be inferred that micromolecules which neutralize the action of snake venoms mechanistically replace endogenous antitoxic serum proteins with venom neutralizing capacity such as produced by some animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11130675     DOI: 10.1016/s0031-9422(00)00229-6

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  57 in total

1.  Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom.

Authors:  Mariane Assafim; Marcos S Ferreira; Flávia S Frattani; Jorge A Guimarães; Robson Q Monteiro; Russolina B Zingali
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 2.  Traditional use of plants against snakebite in Indian subcontinent: a review of the recent literature.

Authors:  Abhijit Dey; Jitendra Nath De
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-10-02

3.  Strategy for early callus induction and identification of anti-snake venom triterpenoids from plant extracts and suspension culture of Euphorbia hirta L.

Authors:  R Amos Samkumar; Dhanaraj Premnath; R S David Paul Raj
Journal:  3 Biotech       Date:  2019-06-14       Impact factor: 2.406

4.  Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2.

Authors:  Mala S Kumar; Amjesh R; Silpa Bhaskaran; Delphin R D; Achuthsankar S Nair; Sudhakaran P R
Journal:  J Mol Model       Date:  2019-03-08       Impact factor: 1.810

5.  Protective Effect of the Sulfated Agaran Isolated from the Red Seaweed Laurencia aldingensis Against Toxic Effects of the Venom of the Snake, Lachesis muta.

Authors:  Ana Cláudia Rodrigues da Silva; Luciana Garcia Ferreira; Maria Eugênia Rabello Duarte; Mutue Toyota Fujii; Eladio Flores Sanchez; Miguel Daniel Noseda; André Lopes Fuly
Journal:  Mar Biotechnol (NY)       Date:  2016-11-25       Impact factor: 3.619

6.  In silico identification of viper phospholipaseA2 inhibitors: validation by in vitro, in vivo studies.

Authors:  Amit Nargotra; Sujata Sharma; Mohd Iqbal Alam; Zabeer Ahmed; Asha Bhagat; Subhash Chander Taneja; Ghulam Nabi Qazi; Surrinder Koul
Journal:  J Mol Model       Date:  2011-03-01       Impact factor: 1.810

7.  Crystallization and preliminary X-ray diffraction analysis of a Lys49-phospholipase A2 complexed with caffeic acid, a molecule with inhibitory properties against snake venoms.

Authors:  Patrícia S Shimabuku; Carlos A H Fernandes; Angelo J Magro; Tássia R Costa; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-01-22

8.  Rosmarinic acid in Argusia argentea inhibits snake venom-induced hemorrhage.

Authors:  Hnin Thanda Aung; Toshiaki Nikai; Masatake Niwa; Yoshiaki Takaya
Journal:  J Nat Med       Date:  2010-05-29       Impact factor: 2.343

9.  Crystallization and preliminary X-ray crystallographic studies of a Lys49-phospholipase A2 homologue from Bothrops pirajai venom complexed with rosmarinic acid.

Authors:  Juliana I dos Santos; Norival A Santos-Filho; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-05-27

10.  In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Authors:  G Sakthivel; Amitabha Dey; Kh Nongalleima; Murthy Chavali; R S Rimal Isaac; N Surjit Singh; Lokesh Deb
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.